Phentermine, as highlighted in clinical trials, offers a practical first-line alternative for patients seeking GLP-1 non-injectable options, although practitioners must balance efficacy with potential adverse effects
In the 18-week study, 9% of patients receiving JANUVIA 100 mg and 17% who received placebo required rescue therapy
doi: 10.2337/dci24-0003
The addition of energy expenditure enhancement via glucagon agonism addresses a limitation inherent to GLP-1-only approaches, which reduce energy intake but do not meaningfully increase energy output
How to Get Retatrutide Legally A walkthrough of every compliant access pathway, with TRIUMPH trial enrollment as the primary route
But like many systems in the body, it can become less reliable due to a variety of factors, including age, diet and other lifestyle habits